89bio Inc (ETNB)
8.75
-0.16
(-1.85%)
USD |
NASDAQ |
Nov 14, 16:00
8.50
-0.25
(-2.86%)
After-Hours: 20:00
89bio Free Cash Flow: -280.54M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -280.54M |
| June 30, 2024 | -165.54M |
| March 31, 2024 | -138.82M |
| December 31, 2023 | -129.19M |
| September 30, 2023 | -121.99M |
| June 30, 2023 | -106.44M |
| March 31, 2023 | -86.83M |
| December 31, 2022 | -81.10M |
| September 30, 2022 | -82.27M |
| June 30, 2022 | -80.92M |
| Date | Value |
|---|---|
| March 31, 2022 | -86.21M |
| December 31, 2021 | -76.84M |
| September 30, 2021 | -62.61M |
| June 30, 2021 | -62.10M |
| March 31, 2021 | -53.54M |
| December 31, 2020 | -46.37M |
| September 30, 2020 | -43.58M |
| June 30, 2020 | -36.83M |
| March 31, 2020 | -29.24M |
| December 31, 2019 | -25.60M |
Free Cash Flow Range, Past 5 Years
-280.54M
Minimum
Sep 2024
-25.60M
Maximum
Dec 2019
-89.83M
Average
-81.01M
Median
Free Cash Flow Benchmarks
| Madrigal Pharmaceuticals Inc | -438.32M |
| Eli Lilly and Co | -2.275B |
| Viking Therapeutics Inc | -74.25M |
| Akero Therapeutics Inc | -212.64M |
| NovaBay Pharmaceuticals Inc | -4.812M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -145.36M |
| Cash from Investing (Quarterly) | -8.639M |
| Cash from Financing (Quarterly) | 33.19M |
| Free Cash Flow Per Share (Quarterly) | -1.358 |
| Free Cash Flow Yield | -33.44% |